Daratumumab in HLA Desensitization Prior to Transplantation

NCT05300451 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Transplant

Interventions

BIOLOGICAL: Daratumumab and hyaluronidase-fihj

Sponsor

Barry A. Boilson

Collaborators

[object Object]